AI-assisted, human-published
10/19/2026 /Funding Events
Souffle Therapeutics Secures $135M Series B in Oversubscribed Round
Leading investors back Souffle’s RNA therapy platform as the company closes a $135 million Series B, underscoring confidence in its development trajectory.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com